Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endometrial Cancer, Endometrial Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04106414
What this trial is testing

Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment

Who this might be right for
Endometrial AdenocarcinomaEndometrial Carcinosarcoma
Memorial Sloan Kettering Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT02632448
What this trial is testing

LY2880070 in Participants With Advanced or Metastatic Cancer

Who this might be right for
Solid TumorsColorectal CancerBreast Cancer+9 more
Esperas Pharma Inc. 229
Large-scale testing (Phase 3)Study completedNCT04865289
What this trial is testing

Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension Study

Who this might be right for
Endometrial Neoplasms
Merck Sharp & Dohme LLC 130
Early research (Phase 1)Study completedNCT01273168
What this trial is testing

Endoxifen in Adults With Hormone Receptor Positive Solid Tumors

Who this might be right for
Hormone Receptor-Positive BreastGynecologicDesmoid+1 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT05712889
What this trial is testing

Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 29
Testing effectiveness (Phase 2)Ended earlyNCT03642990
What this trial is testing

NR in Chemo-induced Peripheral Neuropathy

Who this might be right for
Chemotherapy-induced Peripheral NeuropathyBreast Cancer MetastaticPlatinum-resistant Recurrent Ovarian Cancer+2 more
Donna Hammond, PhD 5
Not applicableStudy completedNCT01049126
What this trial is testing

Retrospective Case Study Examining Patient Outcomes Compared to the ChemoFx Assay in Endometrial Cancer Patients

Who this might be right for
Endometrial Cancer
Precision Therapeutics 76
Post-approval studies (Phase 4)Study completedNCT05651282
What this trial is testing

Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial Cancer

Who this might be right for
Endometrium Cancer
University of British Columbia 96
Testing effectiveness (Phase 2)Ended earlyNCT02393248
What this trial is testing

Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)

Who this might be right for
Lung CancerSolid TumorGastric Cancer+8 more
Incyte Corporation 201
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00478426
What this trial is testing

Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Endometrioid AdenocarcinomaEndometrial Serous Adenocarcinoma+5 more
National Cancer Institute (NCI) 34
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Not applicableLooking for participantsNCT05242861
What this trial is testing

Retrospective Study of Brachytherapy

Who this might be right for
BrachytherapyUterine Cervical NeoplasmsUterine Neoplasms+4 more
Zhejiang Cancer Hospital 300
Large-scale testing (Phase 3)Active Not RecruitingNCT05611931
What this trial is testing

Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Who this might be right for
Endometrial Cancer
Karyopharm Therapeutics Inc 257
Early research (Phase 1)Study completedNCT01065662
What this trial is testing

AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies

Who this might be right for
Endometrial CancerOvarian CancerCervical Cancer+2 more
Susana M. Campos, MD 11
Not applicableLooking for participantsNCT07114653
What this trial is testing

The Role of POLE Mutation in High Risk Endometrial Cancer.

Who this might be right for
Endometrial Neoplasms
Far Eastern Memorial Hospital 150
Not applicableStudy completedNCT02506816
What this trial is testing

Preoperative Olaparib Endometrial Carcinoma Study (POLEN)

Who this might be right for
Endometrial Carcinoma
MedSIR 36
Not applicableStudy completedNCT01654458
What this trial is testing

Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer

Who this might be right for
Sexual Dysfunctions, PsychologicalUterine Cervical NeoplasmsOvarian Neoplasms+2 more
Women's College Hospital 398
Not applicableStudy completedNCT03917147
What this trial is testing

Correlation Between Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological Examination

Who this might be right for
Endometrial HyperplasiaEndometrial Neoplasms
University of Campania Luigi Vanvitelli 435
Testing effectiveness (Phase 2)Looking for participantsNCT06730347
What this trial is testing

Lorigerlimab in Participants With Advanced Solid Tumors

Who this might be right for
Platinum-resistant Ovarian CancerPlatinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+8 more
MacroGenics 80
Next Page